Product gold-nanoparticles-custom-nanocomposites

Home > products > gold-nanoparticles> custom-nanocomposites

Catalog	name	Description	price
R-M1-cs8871	Human serum albumin nanoparticles@lidocaine	Human serum albumin is a commonly used carrier molecule for drug delivery due to its biocompatibility and ability to encapsulate or bind with various drugs. When combined with lidocaine, it forms nanoparticles wherein the drug is likely encapsulated or conjugated to the surface of the HSA nanoparticles. The use of HSA nanoparticles as a carrier for lidocaine can have several potential benefits for drug delivery, including improved solubility, controlled release, targeted delivery, and reduced toxicity. These nanoparticles can enhance the pharmacokinetic profile and tissue distribution of lidocaine, potentially improving the effectiveness of the drug for various therapeutic applications.	price>
R-M1-cs8872	Human blood albumin nanoparticles@bulleyaconitine A (100nm)	Human blood albumin nanoparticles coated with bulleyaconitine A (100nm)" represents a drug delivery system wherein human blood albumin nanoparticles are employed to deliver bulleyaconitine A, and the size of the resulting nanoparticles is around 100 nanometers. This approach may hold promise for the development of more effective and targeted therapies for conditions amenable to bulleyaconitine A treatment.	price>
R-M1-8889	BaTiO3@MnO2 Nanoparticles	BaTiO3@MnO2 nanoparticles in a core-shell structure can offer unique properties and applications.For example, the core-shell structure may be engineered to exhibit enhanced dielectric properties, improved photocatalytic activity, or optimized electrochemical performance, depending on the specific intended application.	price>
R-M1-8895	Hyaluronic acid-ZIF-8 drug loading(Chloroquine and 2-Deoxy-D-glucose) 100-200nm	Hyaluronic acid-ZIF-8 drug loading refers to a process in which the drug delivery system composed of hyaluronic acid and zeolitic imidazolate framework-8 (ZIF-8) is utilized to load specific drugs.The process of hyaluronic acid-ZIF-8 drug loading with Chloroquine and 2-Deoxy-D-glucose likely involves encapsulating these drugs within the pores of the ZIF-8 framework in combination with hyaluronic acid. The resulting drug delivery system can potentially target cancer cells through the CD44-HA interactions while delivering the loaded drugs to specific cellular targets, taking advantage of the specific properties of both the drugs and the carrier system.	price>
R-M1-9004	Niobium carbide(few layer),±50nm	As a few-layer material, niobium carbide may have potential applications in various fields, including electronics, energy storage, catalysis, and nanocomposites. Its 2D nature could make it suitable for use in nanoelectronics, where its electronic properties could be harnessed for next-generation devices. Additionally, its high melting point and strength make it a strong candidate for reinforcement in composite materials. In the field of catalysis, the high surface area of few-layer niobium carbide could make it an effective catalyst in various chemical reactions.	price>
R-M1-9030	MoS2/SnO2 nanocomposites	MoS2/SnO2 nanocomposites are materials that are formed by combining molybdenum disulfide (MoS2) and tin dioxide (SnO2) at the nanoscale level.These nanocomposites have potential applications in fields such as energy storage,catalysis,sensors,and electronics.For example,they can be used as electrode materials in lithium-ion batteries, catalysts for chemical reactions,or as sensing elements in gas sensors.	price>
R-M1-9031	WS2@MoS2 nanocomposites	A WS2@MoS2 nanocomposite refers to a material composed of tungsten disulfide (WS2) encapsulated within molybdenum disulfide (MoS2) layers. This nanocomposite structure provides a unique combination of the properties of both WS2 and MoS2, resulting in potential applications in various fields.WS2 is a semiconductor material with a layered structure similar to MoS2. Both materials belong to a class of materials called transition metal dichalcogenides (TMDs).The resulting nanocomposite structure could potentially exhibit novel electronic and optoelectronic properties, as well as enhanced catalytic or tribological characteristics. It may find applications in areas such as energy storage, catalysis, sensors, and electronic devices.	price>
R-M1-9033	MoS2@Mesoporous Silica,150-300nm	This hybrid material(MoS2@Mesoporous Silica,150-300nm/Molybdenum disulfide particles encapsulate mesoporous silicon) exhibits properties that can be advantageous for various applications, such as energy storage, catalysis, and sensing. Mesoporous silicon provides a high surface area and a well-defined porous structure, which can enhance the dispersion of MoS2 particles and facilitate interactions with other materials. This encapsulation can offer advantages such as protection of MoS2 nanoparticles from agglomeration, improved stability, and controlled release of encapsulated molecules.	price>
R-M2-9422	MTX@ZIF-8 nanoparticles	Methotrexate (MTX)-loaded ZIF-8/Methotrexate@ZIF-8 nanoparticles/ Methotrexate@zeolitic imidazolate framework-8 nanoparticles/MTX@ZIF-8 nanoparticles is a pH sensitive biomimetic drug delivery system. In vitro studies have shown that effective drug release can be achieved in acidic environments.MTX@ZIF-8 Nanoparticles have good thermal stability and minimal weight loss at temperatures up to 400℃.Research shows, MTX@ZIF-8 nanoparticles showed high (drug loading efficiency)DLE (~70%) and EE(encapsulation efficiency) (~ 82%).MTX@ZIF-8 nanoparticles for effective RA(Rheumatoid arthritis) treatment. The encapsulation of MTX in ZIF-8 was verified by UV-Vis spectroscopy (Fig. A) MTX and MTX@ZIF-8 showed the same characteristic absorption peaks at 258 and 302 nm ,indicating the successful loading of MTX into the ZIF-8 structure. Moreover, MTX@ZIF-8 showed a similar XRD pattern to ZIF-8, suggesting the negligible effect of MTX on the crystal structure of ZIF-8 (Fig. B). TGA measurements revealed that ZIF-8 and MTX@ZIF-8 had good thermal stability, with little weight loss at temperatures up to 400 °C (Fig. C) TEM, the roughly spherical shape of bare ZIF-8 changed only slightly after drug loading (Fig. G, H).	price>
R-M1-8153	Co-ZIF-9/TiO2	TiO2 has a poor ability to adsorb, capture, and activate carbon dioxide, resulting in the need to improve its photoreduction ability. Co-ZIF-9 is a material that can effectively adsorb and activate CO2 molecules, improving photoreduction activity. Therefore, using Co-ZIF-9 as a cocatalyst is considered to be a method that can effectively improve the photoreduction performance of carbon dioxide.	price>

...